Surgery for localized prostate cancer after renal transplantation

BJU International

Volumn 95, Issue 3, 2005, Pages 319-322

  Hafron, Jason ^a,b   Fogarty, James D ^a   Wiesen, Ari ^a   Melman, Arnold ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Prostate cancer; Renal transplant; Surgery

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; BLEEDING; BLOOD TRANSFUSION; CANCER RECURRENCE; CLINICAL ARTICLE; DETERIORATION; FEASIBILITY STUDY; FOLLOW UP; HUMAN; KIDNEY TRANSPLANTATION; LENGTH OF STAY; MALE; OPERATION DURATION; PERINEAL RADICAL PROSTATECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REVIEW;

AGED; BLOOD LOSS, SURGICAL; FEASIBILITY STUDIES; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; LENGTH OF STAY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHYSICAL EXAMINATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SECOND-LOOK SURGERY;

EID: 14144249581     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05291.x     Document Type: Review

References (25)

1. US Renal Data System. USRDS 2003: Annual Data Report. Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institute of Health; National Institute of Diabetes and Digestive and Kidney Diseases, 2003
2. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988-96. N Engl J Med 2000; 342: 605-12
3. Sheil AG. Patterns of malignancies following renal transplantation. Transplant Proc 1999; 31: 1263-5
4. Penn I. Neoplastic complications of organ transplantation. In Ginns LC, Cosini AB, Morris PJ eds, Transplantation. Malden, MA: Blackwell Science, 1999: 770-81
5. Birkkeland SA, Storm HH, Lamm LU et al. Cancer risk after renal transplantation in the Nordic countries, 1964-86. Int J Cancer 1995; 60: 183-9
6. Cormier L, Lechevallier E, Barrou B et al. Diagnosis and treatment of prostate cancer in renal-transplant recipients. Transplantation 2003; 75: 237-9
7. Malavaud B, Hoff M, Miedouge M, Rostaing L. PSA-based screening for prostate cancer after renal transplant. Transplantation 2000; 69: 2461-2
8. Kinahan TJ, McLoughlin MG, Manson ADC. Radical prostatectomy for localized prostatic carcinoma in the renal transplant patient. J Urol 1991; 146: 104-7
9. Konety BR, Tewari A, Howard RJ et al. Prostate cancer in the post-transplant population. Urology 1998; 52: 428-43
10. Melman A, Boczko J, Figueroa J, Leung AC. Critical surgical techniques for radical perineal prostatectomy. J Urol 2004; 171: 786-90
11. Boczko J, Melman A. Radical perineal prostatectomy in obese patients. Urology 2003; 62: 467-9
12. Bluestein DL, Bostwick DG, Bergstralh EJ, Oesterling JE. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol 1994; 151: 1315-20
13. Cagiannos I, Karakiewicz P, Eastham JA et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 2003; 170: 1798-803
14. Frazier HA, Robertson JE, Paulson DF. Radical prostatectomy. the pros and cons of the perineal versus retropubic approach. J Urol 1992; 147: 888-90
15. Weldon VE, Tavel FR, Neuwirth H. Continence, potency and morbidity after radical perineal prostatectomy. J Urol 1997; 158: 1470-5
16. Ward JF, Zinke H, Bergstralh EJ, Slezak JM, Myers RP, Blute ML. The impact of surgical approach (nerve bundle preservation versus wide local excision) on surgical margins and biochemical recurrence following radical prostatectomy. J Urol 2004; 172: 1328-32
17. Sullivan LD, Weir MJ, Kinahan JF, Taylor DL. A comparison of the relative merits of radical perineal and radical retropubic prostatectomy. BJU Int 2000; 85: 95-100
18. Manson ADC, Landsberg DN. Prostatic carcinoma following renal transplantation. Transpl Proc 1989; 21: 3313-4
19. Multanen MT, Lindell OI. Radical prostatectomy for localized prostatic carcinoma in a renal transplant patient. Scand J Urol Nephrol 1998; 32: 221-2
20. Marcen R, Pascual J, Tato JL et al. Renal transplant outcome after losing the first graft. Transplant Proc 2003; 35: 1679-81
21. Yiou R, Salomon L, Colombel M, Patard JJ, Chopin D, Abbou CC. Perineal approach to radical prostatectomy in kidney transplant recipients with localized prostate cancer. Urology 1999; 53: 822-4
22. Morton JJ, Howe SF, Lowell JA, Stratta RJ, Taylor RJ. Influence of end-stage renal disease and renal transplantation on serum prostate-specific antigen. Br J Urol 1995; 75: 498-501
23. Kinlen LJ. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med 1985; 78: 44-9
24. Penn I. Evaluation of transplant candidates with pre-existing malignancies. Annal Transplantation 1997; 2: 14-7
25. Krochak RJ, Baker DG. Radiation nephritis. clinical manifestations and pathophysiologic mechanisms. Urology 1987; 27: 389-93